Cinacalcet Hydrochloride Impurity III, identified by the CAS number 2436762-80-8, is a chemical compound that serves as an impurity associated with the pharmaceutical agent cinacalcet, which is primarily used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease and for hypercalcemia in patients with parathyroid carcinoma. While specific characteristics of this impurity may not be extensively documented, impurities in pharmaceutical compounds typically exhibit properties such as varying solubility, stability, and reactivity compared to the parent compound. The presence of impurities can affect the efficacy, safety, and quality of the drug product, making their characterization essential in pharmaceutical development. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify impurities, ensuring compliance with regulatory standards. Understanding the characteristics of such impurities is crucial for maintaining the integrity of the drug formulation and ensuring patient safety.

Cinacalcet Hydrochloride iMpuritIII

2436762-80-8: Cinacalcet Hydrochloride Impurity III, identified by the CAS number 2436762-80-8, is a chemical compound that serves as an impurity associated with the pharmaceutical agent cinacalcet, which is primarily used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease and for hypercalcemia in patients with parathyroid carcinoma. While specific characteristics of this impurity may not be extensively documented, impurities in pharmaceutical compounds typically exhibit properties such as varying solubility, stability, and reactivity compared to the parent compound. The presence of impurities can affect the efficacy, safety, and quality of the drug product, making their characterization essential in pharmaceutical development. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify impurities, ensuring compliance with regulatory standards. Understanding the characteristics of such impurities is crucial for maintaining the integrity of the drug formulation and ensuring patient safety.

<p>(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(2-(trifluoromethyl)phenyl)propanamide</p>

CAS 2436762-80-8

Cinacalcet Hydrochloride iMpuritIII

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(2-(trifluoromethyl)phenyl)propanamide

Ref: 54-PC104024

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(2-(trifluoromethyl)phenyl)propanamide

Ref: 54-PC104023